# A Trial of YPEG-rhGH in Children With Short Stature

> **NCT05838885** · PHASE2 · COMPLETED · sponsor: **Xiamen Amoytop Biotech Co., Ltd.** · enrollment: 78 (actual)

## Conditions studied

- Idiopathic Short Stature
- Small for Gestational Age
- Turner Syndrome

## Interventions

- **DRUG:** YPEG-rhGH
- **DRUG:** YPEG-rhGH
- **DRUG:** rhGH
- **DRUG:** rhGH

## Key facts

- **NCT ID:** NCT05838885
- **Lead sponsor:** Xiamen Amoytop Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-15
- **Primary completion:** 2023-10-23
- **Final completion:** 2023-12-19
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05838885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05838885, "A Trial of YPEG-rhGH in Children With Short Stature". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05838885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*